DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/53lktb/dna_probesbased) has announced the addition of the "DNA Probes-Based Diagnostics - Global Business Strategic Report" report to their offering.
This report analyzes the worldwide markets for DNA Probes-based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, Molecular HLA (Human Leukocyte Antigen) Typing, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.
The Report Profiles 63 Companies Including Many Key and Niche Players Such As:
- Abbott Laboratories
- Affymetrix Inc.
- Becton
- Dickinson & Company
- Beckman Coulter Inc.
- bioMérieux
- Celera Group
- Gen-Probe Incorporated
- Genzyme Corporation
- Luminex Molecular Diagnostics
- QIAGEN
- Roche Diagnostics
- Siemens Healthcare Diagnostics Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. MARKET DYNAMICS
2. DNA PROBES-BASED DIAGNOSTICS - A PRIMER
3. PRODUCT OVERVIEW
4. PRODUCT INTRODUCTIONS/INNOVATIONS
5. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVE BUILDER
6. RECENT INDUSTRY ACTIVITY
7. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. LATIN AMERICA
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 63 (including Divisions/Subsidiaries - 79)
Region/Country Players
- The United States 51
- Canada 6
- Japan 2
- Europe 18
- France 1
- Germany 8
- The United Kingdom 3
- Italy 1
- Rest of Europe 5
- Asia-Pacific (Excluding Japan) 2
For more information visit http://www.researchandmarkets.com/research/53lktb/dna_probesbased